Prevalence and distribution of cognitive impairment no dementia (CIND) among the aged population and the analysis of socio-demographic characteristics: The community-based cross-sectional study

Alzheimer Disease and Associated Disorders

Volumn 23, Issue 2, 2009, Pages 130-138

  Fei, Ma ^a   Qu, Yi Cheng ^a   Wang, Ting ^a   Yin, Jiong ^a   Bai, Jing Xu ^a   Ding, Qi Han ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

CIND; Distribution; Elderly; Prevalence; Risk factors

Indexed keywords

AGED; AGING; ARTICLE; BLOCK DESIGN; BOSTON NAMING TEST; CHINA; CLINICAL TRIAL; COGNITIVE DEFECT; COMMUNITY ASSESSMENT; CROSS-SECTIONAL STUDY; DEMENTIA; DEMOGRAPHY; EDUCATIONAL STATUS; FEMALE; GERIATRIC DEPRESSION SCALE; GERIATRIC PATIENT; HEALTH SURVEY; HUMAN; INCOME; LOGICAL MEMORY; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MINI MENTAL STATE EXAMINATION; MULTICENTER STUDY; NATIONAL ADULT READING TEST; NEUROPSYCHOLOGICAL TEST; OCCUPATION; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOMETRY; QUESTIONNAIRE; REY AUDITORY VERBAL LEARNING TEST; RISK FACTOR; SOCIAL ASPECT; STATE TRAIT ANXIETY INVENTORY; VISUAL REPRODUCTION; ASIAN; COMPARATIVE STUDY; EARLY DIAGNOSIS; PERSONALITY TEST; PSYCHOLOGICAL ASPECT; STATISTICAL MODEL; STATISTICS;

AGED; AGING; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DEMENTIA; EARLY DIAGNOSIS; EDUCATIONAL STATUS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MARITAL STATUS; NEUROPSYCHOLOGICAL TESTS; PERSONALITY INVENTORY; PREVALENCE; PSYCHOMETRICS; QUESTIONNAIRES; RISK FACTORS;

EID: 67651046954     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e318190a59d     Document Type: Article

References (48)

1. Linn RT, Wolf PA, Bachman DL, et al. The-preclinical phaseof probable Alzheimer's disease: a 13-year prospective study of the Framingham Cohort. Arch Neurol. 1995;52:485-490.
2. Collie A, Maruff P. The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment. Neurosci Biobehav Rev. 2000;24:365-374. (Pubitemid 30227252)
3. Mickes L, Wixted JT, Fennema-Notestine C, et al. Progressive impairment on neuropsychological tasks in a longitudinal study of preclinical Alzheimer's disease. Neuropsychology. 2007;21:696-705. (Pubitemid 350116513)
4. Di Carlo A, Lamassa M, Baldereschmi M, et al. CIND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementia. Neurology. 2007;69:2186-2187. (Pubitemid 46848623)
5. Graham JE, Rockwood K, Beattie BL, et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet. 1997;349:1793-1796. (Pubitemid 27257555)
6. Kudo T, Imaizumi K, Tanimukai H, et al. Are cerebrovascular factors involved in Alzheimer's disease? Neurobiol Aging. 2000;21:215-224.
7. Londos E, Passant U, Brun A, et al. Clinical Lewy body dementia and the impact of vascular components. Int J Geriatr Psychiatry. 2000;15:40-49. (Pubitemid 30087913)
8. DeCarli C, Miller BL, Swan GE, et al. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol. 2001;58:643-647.
9. Rogers SL, Farlow MR, Doody RS, et al; Donepezil Study Group. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology. 1998;50:136-145.
10. Rosler M, Anand R, Cicin-Sain A, et al. Efficacy and safety of rivastigmine in patients with Alzheimer's disease: International Randomised Controlled Trial. Br Med J. 1999;318:633-640. (Pubitemid 29192055)
11. Ebly EM, Hogan DB, Parhad IM. Cognitive impairment in the nondemented elderly. Arch Neurol. 1995;52:612-619.
12. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery. Tucson: Neuropsychology Press; 1985.
13. Wechsler D. Wechsler Memory Scale III. London: Psychological Corporation; 1997.
14. Wechsler D. Wechsler Memory Scale-Revised (WMS-R). London: Psychological Corporation; 1997.
15. Rey A. L'examen Clinique en Psychologie. Paris: Presse Universitaire de France; 1964.
16. Lezak MD. Neuropsychological Assessment. New York: Oxford University Press; 1983.
17. Kaplan EF, Goodglass H, Weintraub S. The Boston Naming Test. Philadelphia: Lea & Febiger; 1983.
18. Lucas JA, Ivnik RJ, Smith GE, et al. Mayo's older Americans normative studies: category fluency norms. J Clin Exp Neuropsychol. 1998;20:194-200.
19. Wechsler D. Wechsler Adult Intelligence Scale (WAIS-III). 3rd ed. New York: Psychological Corporation; 1997.
20. Spreen O, Benton AL. Neurosensory Centre Comprehensive Examination for Aphasia. Victoria, BC: University of Victoria; 1977.
21. Nelson HE, Willison J. National Adult Reading Test (NART): Test Manual. Windsor, UK: NFER-Nelson; 1991.
22. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a Geriatric Depression Screening Scale: a preliminary report. J Psychiatr Res. 1982;17:37-49.
23. Spielberger CD. State-Trait Anxiety Inventory: A Comprehensive Bibliography. Palo Alto, CA: Consulting Psychologists Press; 1984.
24. Jorm AF, Jacomb PA. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med. 1989;19:1015-1022.
25. Beckett LA, Scherr PA, Evans DA. Population prevalence estimates from complex samples. J Clin Epidemiol. 1992;45: 393-402.
26. Fleiss J. Statistical Methods for Rates and Proportions. New York: John Wiley & Sons; 1981.
27. Di Carlo A, Baldereschi M, Amaducci L, et al. Cognitive impairment without dementia in older people: prevalence, vascular risk factors, impact on disability. The Italian Longitudinal Study on Aging. J Am Geriatr Soc. 2000;48:775-782. (Pubitemid 30457415)
28. Palmer K, Wang H-X, Backman L, et al. Differential evolution of cognitive impairment in nondemented older persons: results from the Kungsholmen project. Am J Psychiatry. 2002; 159:436-442. (Pubitemid 34184739)
29. Unverzagt FW, Gao S, Baiyewu O, et al. Prevalence of cognitive impairment. Data from the Indianapolis Study of Health and Aging. Neurology. 2001;57:1655-1662.
30. Bischkopf J, Busse A, Angermeyer MC. Mild cognitive impairment - a review of prevalence, incidence and outcome according to current approaches. Acta Psychiatr Scand. 2002;106:403-414. (Pubitemid 35335139)
31. Vliet EC, Manly J, Tang MX, et al. The neuropsychological profiles of mild Alzheimer's disease and questionable dementia as compared to age-related cognitive decline. J Int Neuropsychol Soc. 2003;9:720-732. (Pubitemid 36889599)
32. Looi JC, Sachdev PS. Differentiation of vascular dementia from AD on neuropsychological tests. Neurology. 1999;53: 670-678.
33. Chen P, Ratcliff G, Belle SH, et al. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology. 2000;55:1847-1853. (Pubitemid 32103967)
34. Chen P, Ratcliff G, Belle SH, et al. Patterns of cognitive decline in presymptomatic Alzheimer Disease. Arch Gen Psychiatry. 2001;58:853-858.
35. Bozoki A, Giordani B, Heidebrink JL, et al. Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss. Arch Neurol. 2001;58:411-416. (Pubitemid 32217457)
36. Di Carlo A, Baldereschi M, Amaducci L, et al. Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study. J Am Geriatr Soc. 2002;50:41-46. (Pubitemid 34053021)
37. Hanninen T, Koivisto K, Reinikainen KJ, et al. Prevalence of aging-associated cognitive decline in an elderly population. Age Aging. 1996;25:201-205. (Pubitemid 26152035)
38. Koivisto K, Reinikainen KJ, Hanninen T, et al. Prevalence of age associated memory impairment in a randomly selected population from eastern Finland. Neurology. 1995;45: 741-747.
39. Fratiglioni L, Viitanen M, von Strauss E, et al. Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology. 1997;48:132-138.
40. Prince M, Lewis G, Bird A, et al. A longitudinal study of factors predicting change in cognitive test scores over time, in an older hypertensive population. Psychol Med. 1996;26: 555-568. (Pubitemid 26142499)
41. Farrer LA, Sherbation T. Association between angiotensinconverting enzyme and Alzheimer disease. Arch Neurol. 2000; 57:210-214. (Pubitemid 30097188)
42. Terreni L, Fogliarino S, Quadri P, et al. Tumor necrosis factor alpha polymorphism C-850T is not associated with Alzheimer's disease and vascular dementia in an Italian population. Neurosci Lett. 2003;344:135-137. (Pubitemid 36628023)
43. Qiu C, Karp A, von Strauss E, et al. Lifetime principal occupation and risk of Alzheimer's disease in the Kungsholmen project. Am J Ind Med. 2003;43:204-211. (Pubitemid 36173114)
44. Kalmijn S, Feskens EJ, Launer LJ, et al. Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am J Epidemiol. 1997;145:33-41. (Pubitemid 27009055)
45. La Vecchia C, Negri E, Pagano R, et al. Education, prevalence of disease, and frequency of health care utilization. The 1983 Italian National Health Survey. J Epidemiol Community Health. 1987;41:161-165.
46. Hultsch DF, Hertzog C, Small BJ, et al. Use it or lose it: engaged lifestyle as a buffer of cognitive decline in aging? Psychol Aging. 1999;14:245-263.
47. Richards M, Hardy R, Wadsworth ME. Does active leisure protect cognition? Evidence from a national birth cohort. Soc Sci Med. 2003;56:785-792. (Pubitemid 36135809)
48. Wilson RS, Barnes LL, Mendes de Leon CF, et al. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology. 2002;59:364-370. (Pubitemid 34857928)